Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 15
2003 21
2004 20
2005 20
2006 16
2007 21
2008 27
2009 38
2010 50
2011 66
2012 66
2013 78
2014 82
2015 96
2016 112
2017 116
2018 113
2019 152
2020 163
2021 184
2022 223
2023 178

Text availability

Article attribute

Article type

Publication date

Search Results

1,642 results

Results by year

Filters applied: . Clear all
Page 1
Validation of the imatinib-therapy failure model.
Zhang X, Gale RP, Liu B, Huang J, Zhang Y, Du X, Weng J, Li W, Xu N, Liu X, Chen C, Lin H, Li G, Liang R, Liu Z, Wang X, Zhang Y, Han Y, Liu C, Hu J, Lin L, Yang W, Liu Z, Meng L, Tu C, Zheng C, Zhou Z, Bai Y, Qiu H, Chen S, Li F, Guo J, Liu Z, Sun H, Zhou L, Feng R, Sun X, Huang X, Jiang Q. Zhang X, et al. Among authors: liu x. Leukemia. 2023 May;37(5):1166-1169. doi: 10.1038/s41375-023-01875-3. Epub 2023 Mar 27. Leukemia. 2023. PMID: 36973351 No abstract available.
CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K, Liang X, De Rossi G, Ryter SW, Xiong K, Chu SG, Liu X, Ith B, Celada LJ, Romero F, Robertson MJ, Esposito AJ, Poli S, El-Chemaly S, Perrella MA, Shi Y, Whiteford J, Rosas IO. Tsoyi K, et al. Among authors: liu x. Am J Respir Crit Care Med. 2021 Aug 1;204(3):312-325. doi: 10.1164/rccm.202008-3100OC. Am J Respir Crit Care Med. 2021. PMID: 33784491 Free PMC article.
Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
Zhang J, Chen B, Li H, Wang Y, Liu X, Wong KY, Chan WN, Chan AK, Cheung AH, Leung KT, Dong Y, Pan Y, Ke H, Liang L, Zhou Z, Xiao J, Wong CC, Wu WK, Cheng AS, Ma BB, Yu J, Lo KW, Kang W; Ka Fai To. Zhang J, et al. Among authors: liu x. J Pathol. 2023 Feb;259(2):205-219. doi: 10.1002/path.6033. Epub 2022 Dec 17. J Pathol. 2023. PMID: 36373776
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Jiang Q, Li Z, Qin Y, Li W, Xu N, Liu B, Zhang Y, Meng L, Zhu H, Du X, Chen S, Liang Y, Hu Y, Liu X, Song Y, Men L, Chen Z, Niu Q, Wang H, Lu M, Yang D, Zhai Y, Huang X. Jiang Q, et al. Among authors: liu x. J Hematol Oncol. 2022 Aug 18;15(1):113. doi: 10.1186/s13045-022-01334-z. J Hematol Oncol. 2022. PMID: 35982483 Free PMC article. Clinical Trial.
Peptidoglycan-based immunomodulation.
Sun Q, Liu X, Li X. Sun Q, et al. Among authors: liu x. Appl Microbiol Biotechnol. 2022 Feb;106(3):981-993. doi: 10.1007/s00253-022-11795-4. Epub 2022 Jan 25. Appl Microbiol Biotechnol. 2022. PMID: 35076738 Review.
Magnetic nanomaterials-mediated neuromodulation.
Lu X, Li G, Jiao W, Li K, Zhang T, Liu X, Fan H. Lu X, et al. Among authors: liu x. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jul-Aug;15(4):e1890. doi: 10.1002/wnan.1890. Epub 2023 Apr 23. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 37089064 Review.
1,642 results